Medical data collected for each patient in order to correlate biological data (including PDTO response to treatment) with clinical response are indicated in Table 2.
Perréard M., Florent R., Divoux J., Grellard J.M., Lequesne J., Briand M., Clarisse B., Rousseau N., Lebreton E., Dubois B., Harter V., Lasne-Cardon A., Drouet J., Johnson A., Le Page A.L., Bazille C., Jeanne C., Figeac M., Goardon N., Vaur D., Micault E., Humbert M., Thariat J., Babin E., Poulain L., Weiswald L.B, & Bastit V. (2023). ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies. BMC Cancer, 23, 223.
Publication 2023
Administration regimen Albumin Alcohol Biological Cancer Capsular Chemotherapy Ecog EmbolizationLeukocytesLymph node metastasis Neutrophils Patient Tobacco Vascular
Corresponding Organization :
Other organizations :
Cancers et Préventions, Centre François Baclesse, Université de Lille, Laboratoire de Physique Corpusculaire de Caen, École Nationale Supérieure d'Ingénieurs de Caen
Histological diagnosis type, squamous differentiation, keratinization type, p16 status
Serum neutrophils, albumin and leukocytes levels
Surgical margin
Lymph node metastasis with or without capsular rupture
Vascular or lymphatic embolization
Perineural invasion
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required